Loading clinical trials...
Loading clinical trials...
A Phase II Study of TKI258 in Patients With Castration-resistant Prostate Cancer
Conditions
Interventions
TKI258
Locations
2
South Korea
Korean Cancer Study Group
Seoul, Chongro-ku, South Korea
Korea University Anam Hospital
Seoul, Seongbuk-gu, Inchon-ro, South Korea
Start Date
November 1, 2012
Primary Completion Date
December 1, 2014
Completion Date
October 1, 2016
Last Updated
February 18, 2021
NCT02955082
NCT00667199
NCT00411528
NCT01194960
NCT02691975
NCT00286091
Lead Sponsor
Korean Cancer Study Group
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions